Last reviewed · How we verify
BCT197
At a glance
| Generic name | BCT197 |
|---|---|
| Also known as | Acumapimod |
| Sponsor | Mereo BioPharma |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation (PHASE2)
- Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease (PHASE2)
- Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery (PHASE2)
- The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants (PHASE1)
- The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |